ANNX Q1 2026 Earnings Clinical Pipeline Progress Drives EPS Beat as Stock Dips on Broader Biotech Headwinds SHEL Q1 2026 Earnings Strong EPS Beat Helped by Robust Operations Stock Edges Lower VVV Q1 2026 Earnings EPS Surges 18 Above Estimates Stock Climbs Allient Inc ALNT Q1 2026 Earnings EPS Misses Estimates but Stock Surges Over 12 Canopy Growth CGC Q1 2026 Earnings Deep EPS Miss Casts Shadow Over Cannabis Sector CING Q1 2026 Earnings Deep EPS Miss Overshadowed by Positive Stock Movement